Next, we silenced LOXL2 in stable overexpression ETV4 CRC cells, and the results indicated that silencing LOXL2 weakened the phosphorylation of ERK1/2 induced by ETV4 (Fig.7e). Here, LOXL2 is linked to colorectal carcinoma.